Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Matthieu Benoit

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 20, 2023
[Devil with angel wings - when vitamin A saves lives]Tobias Matthieu Benoit, Stefan Gundermann
European Journal of Haematology|November 6, 2024
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in Relapsed Myeloid NeoplasmsTobias Matthieu Benoit, Adrian Bachofner, Nathan Wolfensberger, et al.
Leukemia & Lymphoma|September 18, 2025
Real-world study of tagraxofusp monotherapy in relapsed or refractory blastic plasmacytoid dendritic cell neoplasmEmanuele Angelucci, Eric Deconinck, Tobias Matthieu Benoit, et al.
Annals of Hematology|August 2, 2025
Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient ProgramMarco Herling, Emanuele Angelucci, Tobias Matthieu Benoit, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|March 20, 2023
[Devil with angel wings - when vitamin A saves lives]Tobias Matthieu Benoit, Stefan Gundermann
European Journal of Haematology|November 6, 2024
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in Relapsed Myeloid NeoplasmsTobias Matthieu Benoit, Adrian Bachofner, Nathan Wolfensberger, et al.
Leukemia & Lymphoma|September 18, 2025
Real-world study of tagraxofusp monotherapy in relapsed or refractory blastic plasmacytoid dendritic cell neoplasmEmanuele Angelucci, Eric Deconinck, Tobias Matthieu Benoit, et al.
Annals of Hematology|August 2, 2025
Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient ProgramMarco Herling, Emanuele Angelucci, Tobias Matthieu Benoit, et al.
Pageof 1